Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Washington University School of Medicine
Lund University Hospital
Cedars-Sinai Medical Center
Stanford University
Central Hospital, Nancy, France
Case Comprehensive Cancer Center
Stanford University
Case Comprehensive Cancer Center
Netherlands Open University